163 related articles for article (PubMed ID: 3661817)
21. Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids.
Malarkey WB; Strauss RH; Leizman DJ; Liggett M; Demers LM
Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1385-90. PubMed ID: 1835565
[TBL] [Abstract][Full Text] [Related]
22. [Use of testosterone and anabolic androgenic steroids in sport].
Medraś M; Jóźków P
Endokrynol Pol; 2009; 60(3):204-9. PubMed ID: 19569021
[TBL] [Abstract][Full Text] [Related]
23. Pituitary function test and endocrine status in patient with cirrhosis of the liver before and after hepatic transplantation.
Seehofer D; Steinmueller T; Graef KJ; Rayes N; Wiegand W; Tullius SG; Settmacher U; Neuhaus P
Ann Transplant; 2002; 7(2):32-7. PubMed ID: 12416470
[TBL] [Abstract][Full Text] [Related]
24. Neuromuscular and hormonal adaptations in athletes to strength training in two years.
Häkkinen K; Pakarinen A; Alen M; Kauhanen H; Komi PV
J Appl Physiol (1985); 1988 Dec; 65(6):2406-12. PubMed ID: 3215840
[TBL] [Abstract][Full Text] [Related]
25. Relationships between training volume, physical performance capacity, and serum hormone concentrations during prolonged training in elite weight lifters.
Häkkinen K; Pakarinen A; Alén M; Kauhanen H; Komi PV
Int J Sports Med; 1987 Mar; 8 Suppl 1():61-5. PubMed ID: 3108174
[TBL] [Abstract][Full Text] [Related]
26. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
[TBL] [Abstract][Full Text] [Related]
27. Serum lipids in power athletes self-administering testosterone and anabolic steroids.
Alén M; Rahkila P; Marniemi J
Int J Sports Med; 1985 Jun; 6(3):139-44. PubMed ID: 4030188
[TBL] [Abstract][Full Text] [Related]
28. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
[TBL] [Abstract][Full Text] [Related]
29. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels.
Andersson AM; Juul A; Petersen JH; Müller J; Groome NP; Skakkebaek NE
J Clin Endocrinol Metab; 1997 Dec; 82(12):3976-81. PubMed ID: 9398699
[TBL] [Abstract][Full Text] [Related]
30. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
31. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
Matsumoto AM
J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
[TBL] [Abstract][Full Text] [Related]
32. [Endocrine effects of doping with androgenic anabolic steroids].
Birkeland KI; Jørgensen J; Hemmersbach P
Tidsskr Nor Laegeforen; 1994 Feb; 114(4):426-8. PubMed ID: 8009475
[TBL] [Abstract][Full Text] [Related]
33. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men.
Bergendahl M; Aloi JA; Iranmanesh A; Mulligan TM; Veldhuis JD
J Clin Endocrinol Metab; 1998 Jun; 83(6):1967-75. PubMed ID: 9626127
[TBL] [Abstract][Full Text] [Related]
34. Serum hormones during prolonged training of neuromuscular performance.
Häkkinen K; Pakarinen A; Alén M; Komi PV
Eur J Appl Physiol Occup Physiol; 1985; 53(4):287-93. PubMed ID: 4039254
[TBL] [Abstract][Full Text] [Related]
35. Hypothalamic-pituitary-testicular axis and seminal parameters in hyperthyroid males.
Abalovich M; Levalle O; Hermes R; Scaglia H; Aranda C; Zylbersztein C; Oneto A; Aquilano D; Gutierrez S
Thyroid; 1999 Sep; 9(9):857-63. PubMed ID: 10524563
[TBL] [Abstract][Full Text] [Related]
36. Testosterone suppression of the HPT axis.
MacIndoe JH; Perry PJ; Yates WR; Holman TL; Ellingrod VL; Scott SD
J Investig Med; 1997 Oct; 45(8):441-7. PubMed ID: 9394096
[TBL] [Abstract][Full Text] [Related]
37. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
38. Changes in neuromuscular performance and muscle fiber characteristics of elite power athletes self-administering androgenic and anabolic steroids.
Alén M; Häkkinen K; Komi PV
Acta Physiol Scand; 1984 Dec; 122(4):535-44. PubMed ID: 6524396
[TBL] [Abstract][Full Text] [Related]
39. Testosterone concentrations in female athletes and ballet dancers with menstrual disorders.
Łagowska K; Kapczuk K
Eur J Sport Sci; 2016; 16(4):490-7. PubMed ID: 25951882
[TBL] [Abstract][Full Text] [Related]
40. Endocrine consequences of long-term intrathecal administration of opioids.
Abs R; Verhelst J; Maeyaert J; Van Buyten JP; Opsomer F; Adriaensen H; Verlooy J; Van Havenbergh T; Smet M; Van Acker K
J Clin Endocrinol Metab; 2000 Jun; 85(6):2215-22. PubMed ID: 10852454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
